SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results
March 29, 2022 16:30 ET
|
SAB Biotherapeutics, Inc.
SAB executing on its strategy to build a proprietary immune and autoimmune disorders pipeline, including respiratory diseases that affect immunocompromised patients Plans to announce full data...